Final results: Modern vaccine with 94% efficiency ] distribution of first doses at the beginning of the year
![Final results: Modern vaccine with 94% efficiency ] distribution of first doses at the beginning of the year](/cnt/019de378-603e-7d8c-91a9-e1c9a87aebdb__m.webp)
Final results from tests of Moderna vaccines v. David-19 have confirmed the efficiency of 94%, and none of those vaccinated has developed any serious diseases, the company has said. The American company is presenting data to regulators in the United States, Europe and Kingdom as part of the effort to obtain licenses [...]
The American company is presenting data to regulators in the United States, Europe and Kingdom as part of the effort to obtain emergency licenses.
It expects the Food and Drug Administration (FDA) in the US to consider the summit requirement on December 17th, Writes The Guardian, follows Periscope.
The UK has acquired 7 million doses of vaccine, 5 million on the day Moderna announced its internal results with efficiency of 94.5 percent.
Although the company has made arrangements all over the globe, the US will get access to the first one. Moderna said she expects the first 20 million doses of vaccines to be available at the end of this year. /Periscope











